Document is current
Any future updates will be listed below
-
Authors
Korpan, Martin
Puhr, Hannah Christina
Prager, Gerald Wolfgang
Ilhan-Mutlu, Aysegül
-
Funding
Funding for this research was provided by:
Medical University of Vienna
- License Information
-
More Information
Article History
Received: 14 August 2024
Accepted: 10 October 2024
First Online: 11 November 2024
Conflict of interest
: M. Korpan declares that he has no competing interests. H.C. Puhr received travel support from Eli Lilly, MSD, Novartis, Pfizer and Roche and received lecture honoraria from Eli Lilly. G.W. Prager: advisories and/or speaker fees: Servier, Bayer, Roche, Amgen, Merck, MSD, BMS, Sanofi, Lilly, Astra Zeneca, Astellas, Pierre-Fabre, Incyte, Arcus, CECOG. A. Ilhan-Mutlu: participation in advisory boards organized by MSD, Servier, Daiichi Sankyo, BMS and Astellas, lecture honoraria from Eli Lilly, Servier, BMS, MSD, Astellas, Astra Zeneca and Daiichi Sankyo, consulting for Astellas, MSD, Amgen, Astra Zeneca and BeiGene, travel support from BMS, Roche, Eli Lilly, Daiichi Sankyo and BeiGene.
